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ABSTRACT 
 
Science and technology have the potential to make major contributions to the development of 
medical devices that can help address the highest burdens of diseases in developing countries.  
This paper examined  how science and technology could assist in speeding the development and 
dissemination of information on  new  health  products that could address the largest health threats 
in  developing  countries. The paper investigated the traits needed by such production to have the 
desired  impact. It  also reviewed the extent to which some medical devices and processes possess 
those traits and discuss the potential of science and technology to develop health products, reveal 
the constrains  on  product development and the mechanism  in overcoming the new health  
products. Towards understanding the potential of science and technology to develop more new 
health products to addressing high-burden diseases, it was therefore recommended that there is 
need to consider the characteristics of diagnostics, drugs, vaccines and medical devices that could 
most effectively and efficiently address the critical continent health problems. Science and 
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technology should focus on bio-technologies that could help improve health products that are 
affordable and appropriate to the circumstances of developing countries, using instrument to 
addressing the most pressing health needs and be appropriate to the health conditions that cause 
the largest burden of diseases in developing countries of the world. 
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1. INTRODUCTION 
 
Science and technological progress have 
contributed substantially as the key driver to 
modern development and  improvement  in  
human  health  system. In facts,  some scientific 
and technological discoveries have been of 
exceptional importance to public health o 
vaccinations for small pox, by  the  discovery of 
the  oral polio vaccine,  more effective  family 
planning devices, treatment of malaria fever and  
other  health threats among children            
including  HIV and AIDS [1,2]. The enhancement 
of medical devices such as bifornicated needles, 
syringes,  the  inoculated  lens,  medical knives 
and the use of X-ray instruments have also had 
an  impact on public health  development  
through science and technology. There are very 
substantial  gains in health that could be 
obtained from the effective implementation of 
existing science  technologies  using well-
known  highly effective  low cost  interventions  
but not widely used  in developing countries in  
reducing maternal  death  and disability  [3]. 
Others include appropriate  speedy  
transportation to hospital on  emergency, 
Obstetric  health  care,  reducing young child 
death  by expanding health  coverage with the 
six basic antigens, morbidity and mortality on 
tuberculosis by expanding case finding cure 
rates using DOTS  approach system,  promoting 
exclusive breast feeding for months,  reducing  
neonatal deaths  by training birth attendants in 
resuscitation, provision of antibodies,  keeping 
the baby warm,  focusing  on the scientific and 
technological matters that concern global 
health [4]. 
 
Experience has shown that there are scientific 
areas that can help improve health in 
developing countries  which  include the 
engineering  of  mosquitoes that  are incapable 
of carrying malaria parasite and other 
transmittable diseases, discovers new drugs and 
develop less effective vaccines [5]. The  health 
conditions resulting in the  largest health threats 
in developing countries which require 
diagnostics, vaccines, drugs and medical devices 
appropriate to the needs of the populace  have 
not been addressed properly.  
 
2. DEFINING SCIENCE AND 
TECHNOLOGY  
 
Science and technology involve  the use of 
scientific investigation  products and tools 
Processes .  I t  involves the application of 
engineering to solve  practical problem of human 
daily life [6]. It  also  concerns with  the use of  
scientific  and applied  techniques, skills,  health  
methods and  materials  used in the production 
of goods and services.  This involves the 
accomplishment of objectives such as scientific 
investigation  and  application of engineering                 
to solve the practical  problem of daily life of 
man. 
 
Technology is basically human health 
knowledge that is used to create products and 
artifacts with the help of innovative tools for 
manufacturing health materials and used in 
communication and learning, securing data and 
transportation for human activities [7]. Thus, 
healthy food products, good habitation 
technologies, public health sanitations and  
production of essential  health needs (drugs) for 
the needy communities are necessary among 
the  health  priorities. 
 
The public institutions involved in science and 
technology need to be aware of their 
responsibilities, regulate, legislate, respect 
human life and society and charged for failure 
or omission, since we live in age in which                 
the power of science becomes evidence every 
day. 
 
Globally, a  better quality of life, the 
advancement in medicine and public health has 
doubtlessly contributed to an increase in the life 
expectancy [8]. Today, expectancy of life is about 
64 years and will probably be more than 70 years 
in 2020 unless pandemic diseases such as 
AIDS, child killer diseases, cancer, and 
endocrine dysfunctions  reverse this picture [6, 
9,10]. 
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Although science and technology help to  relieve 
the situation, diseases known for long time are 
still killing  the poors  and deprived. Thus,  there 
is  need  to  address  the  health threats such as 
cerebrovascular and heart diseases, violence, 
diabetes, stroke, malaria, dengue fever, 
leishmaniasis, filariasis, cholera, viral diarrhea, 
AIDS and Chagas disease such as 
cerebrovascular and heart diseases, violence, 
diabetes, stroke, malaria, dengue fever, 
leishmaniasis, filariasis, cholera, viral diarrhea, 
AIDS among the populace suffering typically 
in the developing countries [11]. 
 
Specifically, it has been observed that  disease 
for  the developing countries  really affected poor 
people living in nearly inhabitable environments.  
Thus, the health sectors  whose strategies 
during the last 20 years were based on equality 
and the promise health for all witness an 
increase of disparities to be seen with the naked 
eye  [3]. Thus,  through  collaborative efforts in 
research, science and technology in the 
universities, research centres and private 
enterprises, there is need to invest in new drug 
vaccine and therapies for the control and 
eradication of  endemic diseases  typically  
among  the  poor countries. 
 
3. POTENTIALS  OF SCIENCE AND 
TECHNOLOGY 
 
Towards improving human health,  scientific 
progress has led to  identifying  four areas in 
which science could be harnessed to address 
some of the gaps noted. Sequencing the 
genomes of important pathogens will help 
scientist understand better why those pathogens 
cause diseases, how they develop resistance 
and  what drugs can best fight them  while 
reducing the onset of resistance [12].  For 
example, the sequencing of mosquito genome 
may allow scientist to engineer mosquitoes so 
that they cannot carry malaria and  spread 
dangerous virus causing Other diseases such as 
lymphatic filariasis.  The development of new 
and better drugs such as hepatitis vaccine will 
facilitate the improvement in information 
technology in chemistry and robotics genetics 
and molecular epidemiology (World Health 
Organization [3]. In addition, a number of DNA 
technology exist that can assist in the desiring 
and manufacturing new and improved hepatitis 
vaccine  [12].  Genetic  modifications of plants is 
possible by enriched genetically modified crops 
to  biofortify plants such as producing  banana 
for vitamins A, E, iron and  zinc ,  to  improve  
protein quality  of rice known as Golden Rice,  
rice-wheat rotation  to significantly enhance food 
production by biotechnology, and  drugs for 
latent  tuberculosis  and vaccines for human 
papilloma virus [13]. 
 
However, the international health programmes 
focus on science and technology to Provide  
opportunities for  health  representatives and  
join with political  intellectuals, activists  and 
economic leaders of the world, in continuing 
constructive dialogue to design concrete health 
projects to enhance the quality of life of the 
populace. Science and technology becomes 
important for all countries in addressing 
traditional developmental issues and in coping 
with increased international flow of  goods and 
services,  control and prevention of rapid spread 
of contaminants and diseases. For example, 
United State International Development, [4] has 
significant programme for many developing 
countries in the areas of health, agricultural 
research,  food  environmental  security,  
eradication of poverty in resource-deficient 
countries,  child survival, safe water, micro-
economic  reform, prevention of and response to 
natural disasters [4]. 
 
The combination of computers, the internet and 
mobile devices has the capacity to Transform 
human health needs.  According to the United 
Nations International Telecommunications Union 
(UN-ITU), by the end of 2016, there were an 
estimated 5.3 billion mobile cellular subscriptions 
worldwide, including 940 million subscriptions to 
3G services. 
 
About 90 percent of the worlds population can 
access mobile  networks, with three-quarters of 
mobile subscribers living in developing 
economies. In some parts of the world, 
telemedicine has been used to overcome life 
threatening health challenges to some extent. 
Telemedicine is the practice of medical and 
public healthcare supported by a mobile device, 
including the use of voice, data and SMS [14]. By 
adopting mobile health (mHealth) in the 
healthcare delivery system, many more people  
will potentially be reached and the health of 
people and communities in most developing  
countries will be greatly enhanced. 
 
The mHealth approach is particularly important 
due to the rapid adoption of mobile phone 
technology in developing countries. While 
mHealth has matured in  industrialized  nations, 
the field is still evolving in most developing 
countries. As mobile technology grows, more and 
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more people acquire mobile phones and other 
mobile devices, making the devices part of their 
everyday lives. It then becomes easier for 
medical personnel to interact with them and 
provide health services, obtain health information 
to aid their researches and make it easy for them 
to provide the right medical solutions to health 
challenges in remote locations. It affords the 
medical personnel the ease of  monitoring their 
patients regardless of their location. With the aid 
of  Smartphone-based applications, it is now 
possible to conduct simple but life-saving 
diagnostic and treatment manuals, tools to 
calculate pulse and respiratory rate as well as 
proper drug dosages at a very minimal cost. 
However, the continued and equitable expansion 
of information communication technology (ICT) 
depends on electricity. The real divide over the 
next 10 years will be between those who have 
access to reliable electricity to power  these 
devices and those who do not. 
 
It is with the intention of reducing various 
diseases associated with unhygienic 
environment in developing world that prompted 
Bill Gates & Melinda Foundation to commission 
Indias Biotechnology Industry Research 
Assiatance Council (BIRAC) to  pick  some 
teams of researchers to receive grants worth $2 
million in total, and  helps  solve the global 
sanitation crisis through innovative toilet 
solutions [15]. Some of the developed toilets are 
high-tech toilets that uses microwave to  convert 
human waste into electricity, solar-powered toilet 
that separates liquids from solids and converts 
them into  commercially viable  end products 
among other inventions. 
 
The World Banks estimated  the annual              
global cost of poor sanitation to be about $260 
billion. 
 
Equally, some 2.5 billion people in the world who 
have no access to modern sanitation and 
toilets [3]. The cost of poor sanitation is not just 
money, but precious lives too if considerations 
are given to the fact that over 1.5 million kids  
that died  every year are due to diarrhea  a 
disease originating from un-sanitized toilets and 
disease such as polio that is still ravaging 
developing countries like wild fire. 
 
Furthermore, towards  improving global health, 
science and technology have viewed the bio-
technologies that can help improve health in 
developing countries. In  addition, scientists 
focus  on  the  extent to which technologies 
would be affordable and appropriate to the 
circumstances of developing countries, using 
instrument addressing the most pressing health 
needs in the next 5 to 10 years [1].  
Furthermore, it focuses on the advanced 
knowledge with important benefits in both rural 
and urban areas in  developing nations and the 
development of  new diagnostics, childhood 
vaccines and drugs,  improve water and 
sanitation, empower women  to protect 
themselves against sexually transmitted 
infections (STIs), HIV and microbicides  [16].  
Other significant areas of global health concerns 
in scientific advancement  supported by  science 
and technology include  improvement of nutrition, 
curing latent chronic infections  and introduction 
of oral rehydration therapy (ORT) which become 
the cornerstone of international effort to control 
diarrheal diseases [17]. 
 
The use of bio-remediation to clean 
contaminated soil or water to promote food 
production to prevent the spread of infectious 
water-borne diseases could be related to 
products of science and technological 
development. 
 
4. CONSTRAINTS TO APPLYING 
SCIENCE AND TECHNOLOGY TO  
GLOBAL HEALTH THREATS 
 
Globally, it appears  that the strength of existing  
products on scientific knowledge could make an 
important differences on the poor  health of the 
people  have not been developed such as the 
development of  drugs for  HIV and malaria 
vaccine. These are several common constraints 
to the development of desired  health  products  
including the new diagnostic, vaccines, drugs, 
and delivery health  services  concerned for  
profit sector.  However, a number of factors have 
hampered the rapid growth of  health care 
system  ranging from moderate health facilities, 
shortage of health personnel, health information 
system, high  illiterate rate among people, and 
power  supply  to bandwidth. 
 
Many people in developing countries lack access 
to health technologies even basic ones such as 
life-saving medicine and medication for asthma 
attack to improve breathing system. Limited 
access  to  other health products such  as 
vaccine, diagnostics for infectious and chronic 
diseases and preventive technologies  such as 
insecticide-treated bed  nets and  various kinds 
of contraceptives are among the constraints. 
The  developing countries are waiting exclusively 
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for technology transfer from the developed 
countries  in the areas of genome of plants, 
microorganism and animal use of fungi, with 
therapeutic actions, recombinant DNA 
technology, and improvement  of conservation 
techniques for biological materials and cloning of 
plants and animals [13]. This signifies to deepen 
the existing crisis, even in the era of 
globalization. It is very difficult for the developing 
countries to gain access to new health 
technologies. Multi-national co-operations with 
expertise in genetic engineering technology 
techniques are involved in vaccines productio n  
with extensive protected industrial              
property rights. They thus doubt the ability of    
low-income individuals  to  afford cost for             
their  health  products that would give them a 
sufficient return on their capital. In addition, they 
doubt that government in  developing   
countries could afford their products  on  
Hepatitis B and  Hemophilus influenza type 
b (Hib) [9]. 
 
Moreover, the  high  cost of developing a new 
product can be very high to bring a new drug 
from research to market.  Given those cost, profit 
making firms will invariably want to use their 
capital to develop a potential rather than develop 
a drug for low-income countries on which the firm 
believes it will not be able to account its 
investment [18]. In addition, vaccine markets 
have some particular constraints to 
entry because the number of firms engaged in 
vaccine production worldwide is small and 
production capacity is limited. Developing 
vaccines for developing countries is also 
complicated because the vaccines  used for the 
immunization programmes in  developing 
countries are  relatively expensive compared 
with developed countries and have an increasing 
divergence  [5]. Another constraints focus on the 
health condition of the developing world  
reflected  the extent to which drugs have been 
developed to address the diseases that mostly  
affect poor people in developing countries. For 
example, only about 3% of approved drugs 
between 1975 and 1999 were relevant to 
infectious and parasitic diseases that were the 
most significant burdens of diseases in 
developing  countries  [13].  Over the same 
period,  only  about 1% of the drugs approved in 
Africa countries were also relevant to the 
numerous tropical diseases ravaging the 
continent.  
 
Diseases such as TB, malaria, African 
trypanosomiasis, Chagas diseases and  
leishmaniasis are at this period bediviling the 
continent. Of all these, only malaria appears to 
be an area of infectious diseases which is 
attracting any substantial investment from 
pharmaceutical manufacturers [19]. 
 
5. ENHANCEMENT OF THE NEEDS  FOR 
NEW HEALTH PRODUCT DEVELOP-
MENT 
 
There is need to consider the characteristics of 
diagnostics, drugs, vaccines and  scientific 
devices that could most effectively and efficiently 
address the  critical  continent health threats  for 
these new products and  poor people with 
financial resources [16]. The  quality of health 
care in developing countries is low           
considering  safety  and  is often poor with    
health systems  that are poorly organize and 
cannot effectively manage logistics.         
Transport  systems  and storage of goods are 
weak and limited electricity  supply  for  regular 
storage of goods at normal temperature for 
potency.  It is important that diagno stics be 
affordable, specific and sensitive for  easy  
treatment. 
 
The ideal drugs  need to be affordable and safe, 
effective, inexpensive and used for many years 
without being susceptible to resistance. It should 
require small doses over a limited period, easy to 
store, transports with  stable temperature. People 
develop resistance for those drugs and some of 
them have serious side- effects  [3]. The world 
need to encourage the development of safer and 
more effective AID drugs,  HIV vaccines and 
mechanism by which women could protect 
themselves better from microbicides  and the 
risks  of HIV / AIDS. 
 
Vaccines and delivery devices must meet the 
most important health needs in the          
developing world. They must be affordable, safe 
and effective, requiring few doses, easy to 
transport and store and would not               
require refrigeration. The ideal vaccines            
should be an inexpensive, combined  with  
many antigens and only one dose would confer 
lifelong immunity against a number of diseases.  
There are gaps in the development of 
diagnostics, drugs, vaccines and medical devices 
that can serve the health needs in  the 
developing world. In general, the public           
sectors have tried to reduce its risks by wanting 
for such products  to be developed by private 
sectors due to its risks to produce products that 
are  expensive to develop and for which an 
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adequate return on investment cannot be 
assured. 
 
However, there are number of steps that could  
encourage a large share in  the  developing 
world such as push and pull mechanisms 
considering their impacts [19]. For example, 
encouraging products development by helping to 
reduce the costs of investment is one type of 
effort related to push mechanism. Push 
mechanisms include direct financing by  the  
government on research activities,           
performing clinical trials and tax credit for 
research and development  [7]. The push 
mechanism can reduce risk and encourage 
investment in product development but they 
provide no certainty that the desired products will 
be produced. 
 
Another set of efforts could focus on pull 
mechanisms, which are intended  to help assure 
a satisfactory return to investors in the event that 
a product is produced. These mechanisms could 
include increasing the uptake of existing 
vaccines, prices, transferable patents, co-
payments, market assurance and tax credits for 
vaccine sales. It is now possible to conduct 
simple but life-saving diagnostic and treatment 
manuals, and tools to calculate pulse, respiratory 
rate, and proper drug dosages. The adaptation of 
inexpensive technology to health care and needs 
is a fast growing trend across the world 
especially in  and for  the  developing countries 
like Nigeria. 
 
6. SUMMARY AND CONCLUSION 
 
Science and  technology have the  potentials  to 
make major contributions to the                   
development of diagnostics, vaccine, drugs and 
medical devices that  address the highest     
burden of diseases both in the under-developed 
and developing countries. Progress in science 
and technology  can help to engineer 
mosquitoes that could not carry diseases, 
discover new drugs and develop less expensive 
and more vaccines for communicable and non-
communicable diseases. Science and 
technology could be appropriate to the needs of 
health conditions that cause the largest                    
burden of diseases in developing countries of 
the world. The new health products  through 
science and  technology should be affordable, 
heat stable,  not requiring refrigeration,  easy to 
store and transport  and require a short course of 
therapy. 
 
The desired health products through science and 
technology could probably require a series of 
measures such as push and pull mechanism that 
are meant to lower the cost of research and 
development for the private sectors on new 
health products. These  could include financial 
assistance of the government on clinical trials, 
offering tax  credits for research and 
development using pull  and push  mechanisms  
focusing on increasing the uptake of existing 
vaccines prizes, transferable patents, and co-
payments, market assurances and tax credits for 
vaccine sales. 
 
Considerable hope for the new product 
development could be placed in public-private 
product development partnerships such as 
Medicine for Malaria Venture, International AIDS  
Vaccine Initiative and the Global Alliance for 
Tuberculosis Drug Development. 
 
7. RECOMMENDATIONS 
 
Towards understanding the potential of                
science and technology to develop more new 
health products and address high-burden 
diseases, the following recommendations were 
made: 
 
1.   There is need to consider the 
characteristics of diagnostics, drugs, 
vaccines and medical devices that          
could most effectively and efficiently 
address the health threats in the 
developing world. 
2.   Science and technology should focus on 
bio-technologies that can help improve 
health products that are affordable and 
appropriate to the circumstances in the 
developing countries  addressing the most 
pressing health needs. 
3.   Science and technology should be 
appropriate to the  health  needs or 
conditions that cause the largest burden of 
diseases in developing countries of the 
world. 
4.   The constraints to applying  science and 
technology to solve global health threats 
should be totally eradicated 
5.   The public  and private  institutions 
involved with science and technology 
should be aware of their responsibility to 
act, regulate, legislate, respecting human 
life and society and charge them in case of 
failure or omission. 
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6.  International  health  programmes based 
on science and technology should provide 
opportunities for representatives to join 
with political  and other  intellectual  and 
economic leaders of the world,  and 
activists in the developing countries 
to continuing constructive dialogue on 
concrete health projects designed  to 
enhance the quality of life of people. 
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